Developing Carrier Complexes for "Caged NO": RuCl(3)(NO)(H(2)O)(2) Complexes of Dipyridylamine, (dpaH), N,N,N'N'-Tetrakis (2-Pyridyl) Adipamide, (tpada), and (2-Pyridylmethyl) Iminodiacetate, (pida).

J M Slocik, R A Kortes, R E Shepherd
{"title":"Developing Carrier Complexes for \"Caged NO\": RuCl(3)(NO)(H(2)O)(2) Complexes of Dipyridylamine, (dpaH), N,N,N'N'-Tetrakis (2-Pyridyl) Adipamide, (tpada), and (2-Pyridylmethyl) Iminodiacetate, (pida).","authors":"J M Slocik,&nbsp;R A Kortes,&nbsp;R E Shepherd","doi":"10.1155/MBD.2000.67","DOIUrl":null,"url":null,"abstract":"<p><p>Delivery agents which can carry the {Ru(NO)}(6) chromophore (\"caged NO\") are desired for vasodilation and for photodynamic therapy of tumors. Toward these goals, complexes derived from [RuCl(3)(NO)(H(2)O)(2)]= (1) have been prepared using dipyridylamine (dpaH) as mono and bis adducts, [Ru(NO)Cl(3)(dpaH)] = (2) and [Ru(NO)Cl(dpaH)(2)]Cl(2) = (3). The dpaH ligands coordinate cis to the Ru(NO) axis.The mono derivative is a model for a potential DNA groove-spanning binuclear complex {[RuNO)Cl(3)](2)(tpada)} = (4) which has two DNA-coordinating Ru(II) centers, photo-labile {Ru(NO)}(6) sites, and a groove-spanning tether moiety.The binuclear assembly is prepared from the tethered dipyridylamine ligand N,N,N',N'-tetrakis(2-pyridylmethyl)adipamide (tpada) which has recently been shown to provide a binuclear carrier complex suited to transporting Ru(II) and Pd(II) agents. A related complex, [Ru(NO)Cl(pida)] = (5) with the {Ru(NO)}(6) moiety bound to (2-pyridylmethyl) iminodiacetate (pida(2-)) is also characterized as a potential \"caged NO\" carrier. Structural information concerning the placement of the pyridyl donor groups relative to the {Ru(NO)}(6) unit has been obtained from (1)H and (13)C NMR and infrared methods, noting that a pyridyl donor trans to NO+ causes \"trans strengthening\" of this ligand for [Ru(NO)Cl(pida)], whereas placement of pyridyl groups cis to NO+ causes a weakening of the N-O bond and a lower NO stretching frequency in the dpa-based complexes.</p>","PeriodicalId":18452,"journal":{"name":"Metal-Based Drugs","volume":"7 2","pages":"67-75"},"PeriodicalIF":0.0000,"publicationDate":"2000-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/MBD.2000.67","citationCount":"8","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Metal-Based Drugs","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/MBD.2000.67","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 8

Abstract

Delivery agents which can carry the {Ru(NO)}(6) chromophore ("caged NO") are desired for vasodilation and for photodynamic therapy of tumors. Toward these goals, complexes derived from [RuCl(3)(NO)(H(2)O)(2)]= (1) have been prepared using dipyridylamine (dpaH) as mono and bis adducts, [Ru(NO)Cl(3)(dpaH)] = (2) and [Ru(NO)Cl(dpaH)(2)]Cl(2) = (3). The dpaH ligands coordinate cis to the Ru(NO) axis.The mono derivative is a model for a potential DNA groove-spanning binuclear complex {[RuNO)Cl(3)](2)(tpada)} = (4) which has two DNA-coordinating Ru(II) centers, photo-labile {Ru(NO)}(6) sites, and a groove-spanning tether moiety.The binuclear assembly is prepared from the tethered dipyridylamine ligand N,N,N',N'-tetrakis(2-pyridylmethyl)adipamide (tpada) which has recently been shown to provide a binuclear carrier complex suited to transporting Ru(II) and Pd(II) agents. A related complex, [Ru(NO)Cl(pida)] = (5) with the {Ru(NO)}(6) moiety bound to (2-pyridylmethyl) iminodiacetate (pida(2-)) is also characterized as a potential "caged NO" carrier. Structural information concerning the placement of the pyridyl donor groups relative to the {Ru(NO)}(6) unit has been obtained from (1)H and (13)C NMR and infrared methods, noting that a pyridyl donor trans to NO+ causes "trans strengthening" of this ligand for [Ru(NO)Cl(pida)], whereas placement of pyridyl groups cis to NO+ causes a weakening of the N-O bond and a lower NO stretching frequency in the dpa-based complexes.

开发“笼化NO”载体配合物:RuCl(3)(NO)(H(2)O)(2)二吡啶胺(dpaH), N,N,N'N'-四(2-吡啶基)己二酰胺(tpada)和(2-吡啶基甲基)亚氨基二乙酸酯(pida)配合物。
能够携带{Ru(NO)}(6)发色团(“笼型NO”)的递送剂被用于血管扩张和光动力治疗肿瘤。为了达到这些目的,用二吡啶胺(dpaH)作为单加合物和双加合物,[Ru(NO)Cl(3)(dpaH)] =(2)和[Ru(NO)Cl(dpaH)(2)]Cl(2) =(3)制备了[RuCl(3)(NO)(H(2)O)(2)]=(1)的配合物。dpaH配体坐标顺Ru(NO)轴。单衍生物是潜在的DNA跨沟双核配合物{[RuNO)Cl(3)](2)(tpada)} =(4)的模型,它具有两个DNA协调的Ru(II)中心,光不稳定的{Ru(NO)}(6)位点和一个跨沟系链片段。双核复合物是由系链二吡啶胺配体N,N,N',N'-四akis(2-吡啶基甲基)己二酰胺(tpada)制备的,该配体最近被证明可以提供适合运输Ru(II)和Pd(II)试剂的双核载体配合物。[Ru(NO)Cl(pida)] =(5)与{Ru(NO)}(6)部分结合(2-吡啶基甲基)亚氨基二乙酸酯(pida(2-))的相关配合物[Ru(NO)Cl(pida)] =(5)也被表征为潜在的“笼化NO”载体。通过(1)H和(13)C核磁共振和红外方法获得了有关吡啶基给体相对于{Ru(NO)}(6)单元的位置的结构信息,注意到吡啶基给体反式到NO+导致该配体对[Ru(NO)Cl(pida)]的“反式强化”,而吡啶基顺式到NO+的位置导致N-O键减弱,并且在dpa基配合物中降低了NO伸展频率。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信